Oliger Christy J. — SEC insider filings

SEC reporting owner CIK 1822092. 31 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2020-08-31 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REATA PHARMACEUTICALS INC (RETA)Director5——17
Karyopharm Therapeutics Inc. (KPTI)Director7——7
Nuvalent, Inc. (NUVL)Director3——6
Replimune Group, Inc. (REPL)Director6——6
Vera Therapeutics, Inc. (VERA)Director3——3
LAVA Therapeutics NV (LVTX)Director2——2
Sierra Oncology, Inc. (SRRA)Director2——2
Bicara Therapeutics Inc. (BCAX)Director1——1
RayzeBio, Inc. (RYZB)Director1——1
Zenas BioPharma, Inc. (ZBIO)Director1——1

Insider filings — Oliger Christy J.

FiledFormIssuerReported transactionsSource
2026-09-024Zenas BioPharma, Inc. (ZBIO)Grant/award (A): 37,000 (derivative) @ $0EDGAR
2026-07-294Bicara Therapeutics Inc. (BCAX)Grant/award (A): 38,950 (derivative) @ $0EDGAR
2026-07-154Nuvalent, Inc. (NUVL)Code (U): 1,324 @ $124 · Disposition to issuer (D): 6,091 · Disposition to issuer (D): 6,119 (derivative)EDGAR
2026-06-184Nuvalent, Inc. (NUVL)Grant/award (A): 3,444 @ $0EDGAR
2026-05-264Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 15,508 @ $0EDGAR
2026-05-264Vera Therapeutics, Inc. (VERA)Grant/award (A): 17,084 (derivative) @ $0EDGAR
2026-04-074Replimune Group, Inc. (REPL)Grant/award (A): 44,500 (derivative) @ $0EDGAR
2025-11-174LAVA Therapeutics NV (LVTX)Disposition to issuer (D): 33,390 (derivative) @ $0EDGAR
2025-06-204Nuvalent, Inc. (NUVL)Grant/award (A): 3,971 @ $0 · Grant/award (A): 6,119 (derivative) @ $0EDGAR
2025-05-294Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 4,600 (derivative) @ $0EDGAR
2025-05-164Vera Therapeutics, Inc. (VERA)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2025-04-034Replimune Group, Inc. (REPL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2025-02-184LAVA Therapeutics NV (LVTX)Grant/award (A): 33,390 (derivative) @ $0EDGAR
2024-06-114Vera Therapeutics, Inc. (VERA)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-05-304Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 69,000 (derivative) @ $0EDGAR
2024-04-034Replimune Group, Inc. (REPL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2024-02-274RayzeBio, Inc. (RYZB)Disposition to issuer (D): 114,579 (derivative)EDGAR
2023-09-264REATA PHARMACEUTICALS INC (RETA)Disposition to issuer (D): 5,565 · Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 106 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 180 (derivative) · +2 moreEDGAR
2023-06-094REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 2,137 (derivative) @ $0EDGAR
2023-05-254Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 34,000 (derivative) @ $0EDGAR
2023-04-044Replimune Group, Inc. (REPL)Grant/award (A): 25,200 (derivative) @ $0EDGAR
2022-07-014Sierra Oncology, Inc. (SRRA)Disposition to issuer (D): 18,000 (derivative) @ $0EDGAR
2022-06-094REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 3,883 @ $34.76 · Grant/award (A): 5,620 (derivative) @ $0EDGAR
2022-05-204Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 23,900 (derivative) @ $0EDGAR
2022-04-054Replimune Group, Inc. (REPL)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2021-12-034Replimune Group, Inc. (REPL)Grant/award (A): 33,000 (derivative) @ $0EDGAR
2021-06-144REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 180 (derivative) @ $83.24EDGAR
2021-06-044Sierra Oncology, Inc. (SRRA)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2021-05-214Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 23,900 (derivative) @ $0EDGAR
2021-04-164REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 1,250 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 106 (derivative) @ $52.85EDGAR
2020-08-314Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 32,800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1822092 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs